Maximize our proprietary library of approximately 2,300 plants and 3,500 plant extracts with ethnomedicinal investigation

Seek potent, next-generation agents with novel mechanisms of action, and cures versus symptom relief

Pursue collaborations with potential corporate partners whose skillsets and know-how are second to none in the clinical development of psychoactive therapies

First compound identified for possible psychoses/schizophrenia indications

ETI’s scientific strategy team consists of leading and globally renowned ethnobotanists, physicians, and pharmacologists, as well as experts in the fields of natural-product chemistry and neuropharmacology